These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25425438)

  • 21. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2010 Dec; 106(11):1681-5. PubMed ID: 19751258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
    Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
    Urologiia; 2015; (3):19-22. PubMed ID: 26390554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary Neurotrophin Levels Increase in Women With Stress Urinary Incontinence After a Midurethral Sling Procedure.
    Antunes-Lopes T; Coelho A; Pinto R; Barros SC; Cruz CD; Cruz F; Silva CM
    Urology; 2017 Jan; 99():49-56. PubMed ID: 27697460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review.
    Rachaneni S; Arya P; Latthe P
    Int Urogynecol J; 2013 Oct; 24(10):1603-9. PubMed ID: 23649686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
    Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
    Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
    Kim SR; Moon YJ; Kim SK; Bai SW
    Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder.
    Fukui S; Aoki K; Morizawa Y; Miyake M; Fujimoto K
    Urology; 2017 May; 103():214-217. PubMed ID: 28161379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary nerve growth factor in patients with symptomatic detrusor overactivity.
    Agilli M; Aydin FN; Cayci T
    Am J Obstet Gynecol; 2015 Feb; 212(2):251-2. PubMed ID: 25305404
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary biomarkers of overactive bladder.
    Tian XJ; Liu C; Liu K; Tang SY
    Chin Med J (Engl); 2019 May; 132(9):1104-1106. PubMed ID: 30888985
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary prostaglandin E₂ was increased in patients with suprapontine brain diseases, and associated with overactive bladder syndrome.
    Yamauchi H; Akino H; Ito H; Aoki Y; Nomura T; Yokoyama O
    Urology; 2010 Nov; 76(5):1267.e13-9. PubMed ID: 20800884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reply: To PMID 25019486.
    Pillalamarri N; Shalom DF
    Am J Obstet Gynecol; 2015 Feb; 212(2):252. PubMed ID: 25305405
    [No Abstract]   [Full Text] [Related]  

  • 35. Acupuncture versus solifenacin for treatment of overactive bladder and its correlation with urine nerve growth factor levels: a randomized, placebo-controlled clinical trial.
    Aydoğmuş Y; Sunay M; Arslan H; Aydın A; Adiloğlu AK; Şahin H
    Urol Int; 2014; 93(4):437-43. PubMed ID: 25033919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
    Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial comment to effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
    Masuda H
    Int J Urol; 2011 Jul; 18(7):531-2. PubMed ID: 21699581
    [No Abstract]   [Full Text] [Related]  

  • 38. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
    Liu HT; Chancellor MB; Kuo HC
    BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.
    Lee SR; Hong CH; Choi YD; Kim JH
    J Urol; 2010 Jun; 183(6):2440-4. PubMed ID: 20403616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT; Kuo HC
    Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.